Your Web Site
UPDATE - Bristol, Pfizer drug shows risk and reward -study (at Reuters)
By Ben Hirschler MUNICH, Sept 2 (Reuters) - Bristol-Myers Squibb (BMY.N: ) and Pfizer's apixaban blood clot preventer raised rates of bleeding in a six-month study, but showed some encouraging signs of protecting at-risk...

